The binding specificity of the marker antibodies Tra-1-60 and Tra-1-81 reveals a novel pluripotency-associated type 1 lactosamine epitope

Glycobiology

Volumn 21, Issue 9, 2011, Pages 1125-1130

  Natunen, Suvi ^a   Satomaa, Tero ^b   Pitkänen, Virve ^a   Salo, Hanna ^b   Mikkola, Milla ^a,c   Natunen, Jari ^b   Otonkoski, Timo ^c,d   Valmu, Leena ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b GLYKOS FINLAND LTD   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

O glycosylation; pluripotency; stem cells; Tra 1 60; Tra 1 81

Indexed keywords

CARBOHYDRATE; EPITOPE; GLYCAN; GLYCOSIDASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY TRA 1 60; MONOCLONAL ANTIBODY TRA 1 81; MUCIN; N ACETYLGLUCOSAMINE; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; EMBRYONIC STEM CELL; GLYCOSYLATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

AMINO SUGARS; ANTIBODIES; ANTIBODY SPECIFICITY; BINDING SITES; BIOLOGICAL MARKERS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; EMBRYONIC STEM CELLS; EPITOPES; FLOW CYTOMETRY; GLYCOSIDE HYDROLASES; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; PLURIPOTENT STEM CELLS; PROTEIN BINDING;

IPS;

EID: 80051526718     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq209     Document Type: Article

References (28)

1. Andrews PW, Banting G, Damjanov I, Arnaud D, Avner P. 1984. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma. 3:347-361. (Pubitemid 15126239)
2. Andrews PW, Casper J, Damjanov I, Duggan-Keen M, Giwercman A, Hata J, von Keitz A, Looijenga LH, Millan JL, Oosterhuis JW, et al. 1996. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int J Cancer. 66:806-816. (Pubitemid 26197951)
3. Badcock G, Pigott C, Goepel J, Andrews PW. 1999. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteo-glycan. Cancer Res. 59:4715-4719. (Pubitemid 29428981)
4. Draper JS, Pigott C, Thomson JA, Andrews PW. 2002. Surface antigens of human embryonic stem cells: Changes upon differentiation in culture. J Anat. 200:249-258. (Pubitemid 34467317)
5. Enver T, Pera M, Peterson C, Andrews PW. 2009. Stem cell states, fates, and the rules of attraction. Cell Stem Cell. 4:387-397.
6. Fujita K, Itoh Y, Wada R, Nagao K, Fujime M. 2006. Embryonal carcinoma producing DU-PAN-2 with burned-out phenomenon in the testis. Int J Urol. 13:473-475. (Pubitemid 43828014)
7. Fukuda MN, Bothner B, Lloyd KO, Rettig WJ, Tiller PR, Dell A. 1986. Structures of glycosphingolipids isolated from human embryonal carcinoma cells. The presence of mono-and disialosyl glycolipids with blood group type 1 sequence. J Biol Chem. 261:5145-5153. (Pubitemid 17204312)
8. Garin-Chesa P, Rettig WJ. 1989. Immunohistochemical analysis of LNT, NeuAc2-3LNT, and Lex carbohydrate antigens in human tumors and normal tissues. Am J Pathol. 134:1315-1327. (Pubitemid 19206318)
9. Heiskanen A, Hirvonen T, Salo H, Impola U, Olonen A, Laitinen A, Tiitinen S, Natunen S, Aitio O, Miller-Podraza H, et al. 2009. Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J. 26:367-384.
10. Hemmoranta H, Satomaa T, Blomqvist M, Heiskanen A, Aitio O, Saarinen J, Natunen J, Partanen J, Laine J, Jaatinen T. 2007. N-glycan structures and associated gene expression reflect the characteristic N-glycosylation pattern of human hematopoietic stem and progenitor cells. Exp Hematol. 35:1279-1292. (Pubitemid 47088781)
11. Huang Y, Mechref Y, Novotny MV. 2001. Microscale nonreductive release of O-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis. Anal Chem. 73: 6063-6069. (Pubitemid 34042226)
12. International Stem Cell Initiative, Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, et al. 2007. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol. 25: 803-816. (Pubitemid 47052190)
13. Kamoshida S, Satoh Y, Yasuda M, Kajiwara H, Tsukinoki K, Osamura RY. 2002. Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors. Oncol Rep. 9:845-851.
14. Lanctot PM, Gage FH, Varki AP. 2007. The glycans of stem cells. Curr Opin Chem Biol. 11:373-380. (Pubitemid 47302845)
15. Mikkola M, Olsson C, Palgi J, Ustinov J, Palomaki T, Horelli-Kuitunen N, Knuutila S, Lundin K, Otonkoski T, Tuuri T. 2006. Distinct differentiation characteristics of individual human embryonic stem cell lines. BMC Dev Biol. 6:40.
16. Pera MF, Blasco-Lafita MJ, Cooper S, Mason M, Mills J, Monaghan P. 1988. Analysis of cell-differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells. Differentiation. 39:139-149. (Pubitemid 19065569)
17. Rettig WJ, Cordon-Cardo C, Ng JS, Oettgen HF, Old LJ, Lloyd KO. 1985. High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants. Cancer Res. 45:815-821. (Pubitemid 15161085)
18. Satomaa T, Heiskanen A, Mikkola M, Olsson C, Blomqvist M, Tiittanen M, Jaatinen T, Aitio O, Olonen A, Helin J, et al. 2009. The N-glycome of human embryonic stem cells. BMC Cell Biol. 10:42.
19. Schopperle WM, DeWolf WC. 2007. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells. 25:723-730. (Pubitemid 46354232)
20. Schopperle WM, Kershaw DB, DeWolf WC. 2003. Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin. Biochem Biophys Res Commun. 300:285-290. (Pubitemid 38375807)
21. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131:861-872. (Pubitemid 350138099)
22. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science. 282:1145-1147. (Pubitemid 28516247)
23. Tsuruta T, Ogawa A, Ishii K, Ikado S. 1997. CA19-9: A possible serum marker for embryonal carcinoma. Urol Int. 58:20-24. (Pubitemid 27101649)
24. Venable A, Mitalipova M, Lyons I, Jones K, Shin S, Pierce M, Stice S. 2005. Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces. BMC Dev Biol. 5:15.
25. Wearne KA, Winter HC, Goldstein IJ. 2008. Temporal changes in the carbohydrates expressed on BG01 human embryonic stem cells during differentiation as embryoid bodies. Glycoconj J. 25:121-136. (Pubitemid 351238189)
26. Wearne KA, Winter HC, O'Shea K, Goldstein IJ. 2006. Use of lectins for probing differentiated human embryonic stem cells for carbohydrates. Glycobiology. 16:981-990. (Pubitemid 44390939)
27. Wright AJ, Andrews PW. 2009. Surface marker antigens in the characterization of human embryonic stem cells. Stem Cell Res. 3:3-11.
28. Yamanaka S. 2009. A fresh look at iPS cells. Cell. 137:13-17.